IFNG and Miyoshi myopathy: These results suggest that lenalidomide and pomalidomide do not to negatively impact PD-L1 expression on MM cells, and that PD-L1 expression on MM cells may be enhanced with ambient IFN-γ elaborated by immune cells in patients receiving these IMiDs.